메뉴 건너뛰기




Volumn , Issue , 2010, Pages 81-101

The uPA/uPAR system and suPAR in HIV infection

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84880835812     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/9781608050062110010181     Document Type: Chapter
Times cited : (2)

References (164)
  • 3
    • 0032722442 scopus 로고    scopus 로고
    • The plasminogen (fibrinolytic) system
    • Collen D. The plasminogen (fibrinolytic) system. Thromb Haemost 1999; 82: 259-70.
    • (1999) Thromb Haemost , vol.82 , pp. 259-270
    • Collen, D.1
  • 5
    • 0033981473 scopus 로고    scopus 로고
    • The plasminogen activation system in tumor growth, invasion, and metastasis
    • Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 2000; 57: 25-40.
    • (2000) Cell Mol Life Sci , vol.57 , pp. 25-40
    • Andreasen, P.A.1    Egelund, R.2    Petersen, H.H.3
  • 6
    • 0030715322 scopus 로고    scopus 로고
    • ECM and cell surface proteolysis: regulating cellular ecology
    • Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997; 91: 439-42.
    • (1997) Cell , vol.91 , pp. 439-442
    • Werb, Z.1
  • 7
    • 0036906177 scopus 로고    scopus 로고
    • uPAR: a versatile signalling orchestrator
    • Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 2002; 3: 932-43.
    • (2002) Nat Rev Mol Cell Biol , vol.3 , pp. 932-943
    • Blasi, F.1    Carmeliet, P.2
  • 8
    • 3242699717 scopus 로고    scopus 로고
    • uPA and uPAR in fibrinolysis, immunity and pathology
    • Mondino A, Blasi F. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol 2004; 25: 450-5.
    • (2004) Trends Immunol , vol.25 , pp. 450-455
    • Mondino, A.1    Blasi, F.2
  • 9
    • 13844276866 scopus 로고    scopus 로고
    • Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?
    • Montuori N, Visconte V, Rossi G, Ragno P. Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules? Thromb Haemost 2005; 93: 192-8.
    • (2005) Thromb Haemost , vol.93 , pp. 192-198
    • Montuori, N.1    Visconte, V.2    Rossi, G.3    Ragno, P.4
  • 10
    • 33744463114 scopus 로고    scopus 로고
    • The urokinase receptor: a ligand or a receptor? Story of a sociable molecule
    • Ragno P. The urokinase receptor: a ligand or a receptor? Story of a sociable molecule. Cell Mol Life Sci 2006; 63: 1028-37.
    • (2006) Cell Mol Life Sci , vol.63 , pp. 1028-1037
    • Ragno, P.1
  • 11
    • 0034672145 scopus 로고    scopus 로고
    • Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection
    • Sidenius N, Sier CF, Ullum H, et al. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 2000; 96: 4091-5.
    • (2000) Blood , vol.96 , pp. 4091-4095
    • Sidenius, N.1    Sier, C.F.2    Ullum, H.3
  • 12
    • 18144395419 scopus 로고    scopus 로고
    • High Plasma Levels of Intact and Cleaved Soluble Urokinase Receptor Reflect Immune Activation and Are Independent Predictors of Mortality in HIV-1-Infected Patients
    • Ostrowski SR, Piironen T, Hoyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H. High Plasma Levels of Intact and Cleaved Soluble Urokinase Receptor Reflect Immune Activation and Are Independent Predictors of Mortality in HIV-1-Infected Patients. J Acquir Immune Defic Syndr 2005; 39: 23-31.
    • (2005) J Acquir Immune Defic Syndr , vol.39 , pp. 23-31
    • Ostrowski, S.R.1    Piironen, T.2    Hoyer-hansen, G.3    Gerstoft, J.4    Pedersen, B.K.5    Ullum, H.6
  • 13
    • 0035992373 scopus 로고    scopus 로고
    • The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau
    • Eugen-Olsen J, Gustafson P, Sidenius N, et al. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau. Int J Tuberc Lung Dis 2002; 6: 686-92.
    • (2002) Int J Tuberc Lung Dis , vol.6 , pp. 686-692
    • Eugen-olsen, J.1    Gustafson, P.2    Sidenius, N.3
  • 14
    • 34250185656 scopus 로고    scopus 로고
    • Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa
    • doi:10.1186/1471-2334-7-41
    • Lawn SD, Myer L, Bangani N, Vogt M, Wood R. Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa. BMC Infect Dis 2007; 7: doi:10.1186/1471-2334-7-41.
    • (2007) , vol.7
    • Lawn, S.D.1    Myer, L.2    Bangani, N.3    Vogt, M.4    Wood, R.5
  • 15
    • 38849186093 scopus 로고    scopus 로고
    • The prognostic value of the suPARnostic ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms
    • Schneider UV, Nielsen RL, Pedersen C, Eugen-Olsen J. The prognostic value of the suPARnostic ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms. BMC Infect Dis 2007; 7:134.: 134.
    • (2007) BMC Infect Dis , vol.7 , pp. 134
    • Schneider, U.V.1    Nielsen, R.L.2    Pedersen, C.3    Eugen-olsen, J.4
  • 16
    • 0029074566 scopus 로고
    • Enzyme-linked immunoabsorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo
    • Mizukami IF, Faulkner NE, Gyetko MR, Sitrin RG, Todd RF. Enzyme-linked immunoabsorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo. Blood 1995; 86: 203-11.
    • (1995) Blood , vol.86 , pp. 203-211
    • Mizukami, I.F.1    Faulkner, N.E.2    Gyetko, M.R.3    Sitrin, R.G.4    Todd, R.F.5
  • 17
    • 0035018480 scopus 로고    scopus 로고
    • Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia
    • Florquin S, van den Berg JG, Olszyna DP, et al. Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia. Kidney Int 2001; 59: 2054-61.
    • (2001) Kidney Int , vol.59 , pp. 2054-2061
    • Florquin, S.1    Van Den Berg, J.G.2    Olszyna, D.P.3
  • 18
    • 33745475888 scopus 로고    scopus 로고
    • Development and validation of a multiplex add-on assay for Sepsis Biomarkers using xMAP technology
    • Kofoed K, Schneider UV, Scheel T, Andersen O, Eugen-Olsen J. Development and validation of a multiplex add-on assay for Sepsis Biomarkers using xMAP technology. Clin Chem 2006; 52: 1284-93.
    • (2006) Clin Chem , vol.52 , pp. 1284-1293
    • Kofoed, K.1    Schneider, U.V.2    Scheel, T.3    Andersen, O.4    Eugen-olsen, J.5
  • 19
    • 34247328556 scopus 로고    scopus 로고
    • Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study
    • doi:10.1186/cc5723
    • Kofoed K, Andersen O, Kronborg G, et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 2007; 11: doi:10.1186/cc5723.
    • (2007) Crit Care , vol.11
    • Kofoed, K.1    Andersen, O.2    Kronborg, G.3
  • 20
    • 2642563088 scopus 로고    scopus 로고
    • The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality
    • Wittenhagen P, Kronborg G, Weis N, et al. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality. Clin Microbiol Infect 2004; 10: 409-15.
    • (2004) Clin Microbiol Infect , vol.10 , pp. 409-415
    • Wittenhagen, P.1    Kronborg, G.2    Weis, N.3
  • 21
    • 33748803031 scopus 로고    scopus 로고
    • Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163
    • Moller HJ, Moestrup SK, Weis N, et al. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163. Crit Care Med 2006; 34: 2561-6.
    • (2006) Crit Care Med , vol.34 , pp. 2561-2566
    • Moller, H.J.1    Moestrup, S.K.2    Weis, N.3
  • 22
    • 13844255818 scopus 로고    scopus 로고
    • Interleukin-6 infusion during human endotoxemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells
    • Ostrowski SR, Plomgaard P, Fischer CP, et al. Interleukin-6 infusion during human endotoxemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells. Scand J Immunol 2005; 61: 197-206.
    • (2005) Scand J Immunol , vol.61 , pp. 197-206
    • Ostrowski, S.R.1    Plomgaard, P.2    Fischer, C.P.3
  • 23
  • 24
    • 43049104122 scopus 로고    scopus 로고
    • Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor
    • Kofoed K, Eugen-Olsen J, Petersen J, Larsen K, Andersen O. Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor. Eur J Clin Microbiol Infect Dis 2008; 27: 375-83.
    • (2008) Eur J Clin Microbiol Infect Dis , vol.27 , pp. 375-383
    • Kofoed, K.1    Eugen-olsen, J.2    Petersen, J.3    Larsen, K.4    Andersen, O.5
  • 25
    • 0036344642 scopus 로고    scopus 로고
    • Soluble urokinase receptor (uPAR, CD 87) is present in serum and cerebrospinal fluid in patients with neurologic diseases
    • Garcia-Monco JC, Coleman JL, Benach JL. Soluble urokinase receptor (uPAR, CD 87) is present in serum and cerebrospinal fluid in patients with neurologic diseases. J Neuroimmunol 2002; 129: 216-23.
    • (2002) J Neuroimmunol , vol.129 , pp. 216-223
    • Garcia-monco, J.C.1    Coleman, J.L.2    Benach, J.L.3
  • 26
    • 33845330610 scopus 로고    scopus 로고
    • Elevated levels of soluble urokinase receptor in serum from mycobacteria infected patients: Still looking for a marker of treatment efficacy
    • Ostrowski SR, Ravn P, Hoyer-Hansen G, Ullum H, Andersen AB. Elevated levels of soluble urokinase receptor in serum from mycobacteria infected patients: Still looking for a marker of treatment efficacy. Scand J Infect Dis 2006; 38: 1028-32.
    • (2006) Scand J Infect Dis , vol.38 , pp. 1028-1032
    • Ostrowski, S.R.1    Ravn, P.2    Hoyer-hansen, G.3    Ullum, H.4    Andersen, A.B.5
  • 27
    • 57849120623 scopus 로고    scopus 로고
    • Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B
    • Zhou H, Wu X, Lu X, Chen G, Ye X, Huang J. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B. Thromb Res 2009; 123: 537-42.
    • (2009) Thromb Res , vol.123 , pp. 537-542
    • Zhou, H.1    Wu, X.2    Lu, X.3    Chen, G.4    Ye, X.5    Huang, J.6
  • 28
    • 17044427042 scopus 로고    scopus 로고
    • Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome
    • Ostrowski SR, Ullum H, Goka BQ, et al. Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome. J Infect Dis 2005; 191: 1331-441.
    • (2005) J Infect Dis , vol.191 , pp. 1331-1441
    • Ostrowski, S.R.1    Ullum, H.2    Goka, B.Q.3
  • 29
    • 33845582685 scopus 로고    scopus 로고
    • Elevated plasma urokinase receptor predicts low birth weight in maternal malaria
    • Ostrowski SR, Shulman CE, Peshu N, et al. Elevated plasma urokinase receptor predicts low birth weight in maternal malaria. Parasite Immunol 2007; 29: 37-46.
    • (2007) Parasite Immunol , vol.29 , pp. 37-46
    • Ostrowski, S.R.1    Shulman, C.E.2    Peshu, N.3
  • 30
    • 7444265832 scopus 로고    scopus 로고
    • Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection
    • Perch M, Kofoed PE, Fischer TK, et al. Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol 2004; 26: 207-11.
    • (2004) Parasite Immunol , vol.26 , pp. 207-211
    • Perch, M.1    Kofoed, P.E.2    Fischer, T.K.3
  • 31
    • 33846428791 scopus 로고    scopus 로고
    • Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity
    • Pawlak K, Pawlak D, Mysliwiec M. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity. Thromb Res 2007; 119: 475-80.
    • (2007) Thromb Res , vol.119 , pp. 475-480
    • Pawlak, K.1    Pawlak, D.2    Mysliwiec, M.3
  • 32
    • 0032774610 scopus 로고    scopus 로고
    • Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis
    • Slot O, Brunner N, Locht H, Oxholm P, Stephens RW. Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis. Ann Rheum Dis 1999; 58: 488-92.
    • (1999) Ann Rheum Dis , vol.58 , pp. 488-492
    • Slot, O.1    Brunner, N.2    Locht, H.3    Oxholm, P.4    Stephens, R.W.5
  • 33
    • 34347265543 scopus 로고    scopus 로고
    • Urokinase receptor variants in tissue and body fluids
    • Hoyer-Hansen G, Lund IK. Urokinase receptor variants in tissue and body fluids. Adv Clin Chem 2007; 44: 65-102.
    • (2007) Adv Clin Chem , vol.44 , pp. 65-102
    • Hoyer-hansen, G.1    Lund, I.K.2
  • 34
    • 52049092484 scopus 로고    scopus 로고
    • Intact and cleaved uPAR forms: diagnostic and prognostic value in cancer
    • Rasch MG, Lund IK, Almasi CE, Hoyer-Hansen G. Intact and cleaved uPAR forms: diagnostic and prognostic value in cancer. Front Biosci 2008; 13: 6752-62.
    • (2008) Front Biosci , vol.13 , pp. 6752-6762
    • Rasch, M.G.1    Lund, I.K.2    Almasi, C.E.3    Hoyer-hansen, G.4
  • 36
    • 0037173009 scopus 로고    scopus 로고
    • Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication
    • Alfano M, Sidenius N, Panzeri B, Blasi F, Poli G. Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication. Proc Natl Acad Sci U S A 2002; 99: 8862-7.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 8862-8867
    • Alfano, M.1    Sidenius, N.2    Panzeri, B.3    Blasi, F.4    Poli, G.5
  • 37
    • 36248931041 scopus 로고    scopus 로고
    • Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion
    • Elia C, Cassol E, Sidenius N, et al. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. J Leukoc Biol 2007; 82: 1212-20.
    • (2007) J Leukoc Biol , vol.82 , pp. 1212-1220
    • Elia, C.1    Cassol, E.2    Sidenius, N.3
  • 38
    • 61849130031 scopus 로고    scopus 로고
    • Ligand-engaged urokinase-type plasminogen activator receptor (uPAR) and activation of the CD11b/CD18 (Mac1) integrin inhibit late events of HIV expression in monocytic cells
    • Alfano M, Mariani SA, Elia C, Pardi R, Blasi F, Poli G. Ligand-engaged urokinase-type plasminogen activator receptor (uPAR) and activation of the CD11b/CD18 (Mac1) integrin inhibit late events of HIV expression in monocytic cells. Blood 2009; 113: 1699-709.
    • (2009) Blood , vol.113 , pp. 1699-1709
    • Alfano, M.1    Mariani, S.A.2    Elia, C.3    Pardi, R.4    Blasi, F.5    Poli, G.6
  • 39
    • 1842787815 scopus 로고    scopus 로고
    • The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling
    • Behrendt N. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling. Biol Chem 2004; 385: 103-36.
    • (2004) Biol Chem , vol.385 , pp. 103-136
    • Behrendt, N.1
  • 40
    • 0035884988 scopus 로고    scopus 로고
    • Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active [9-74] processed variant
    • Vakili J, Standker L, Detheux M, Vassart G, Forssmann WG, Parmentier M. Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active [9-74] processed variant. J Immunol 2001; 167: 3406-13.
    • (2001) J Immunol , vol.167 , pp. 3406-3413
    • Vakili, J.1    Standker, L.2    Detheux, M.3    Vassart, G.4    Forssmann, W.G.5    Parmentier, M.6
  • 41
    • 0345251960 scopus 로고    scopus 로고
    • The urokinase plasminogen activator system as a target for prognostic studies in breast cancer
    • Stephens RW, Brunner N, Janicke F, Schmitt M. The urokinase plasminogen activator system as a target for prognostic studies in breast cancer. Breast Cancer Res Treat 1998; 52: 99-111.
    • (1998) Breast Cancer Res Treat , vol.52 , pp. 99-111
    • Stephens, R.W.1    Brunner, N.2    Janicke, F.3    Schmitt, M.4
  • 42
    • 0037967310 scopus 로고    scopus 로고
    • Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor
    • Ploug M. Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor. Curr Pharm Des 2003; 9: 1499-528.
    • (2003) Curr Pharm Des , vol.9 , pp. 1499-1528
    • Ploug, M.1
  • 44
    • 0025900910 scopus 로고
    • The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator
    • Behrendt N, Ploug M, Patthy L, Houen G, Blasi F, Dano K. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J Biol Chem 1991; 266: 7842-7.
    • (1991) J Biol Chem , vol.266 , pp. 7842-7847
    • Behrendt, N.1    Ploug, M.2    Patthy, L.3    Houen, G.4    Blasi, F.5    Dano, K.6
  • 47
    • 0031583964 scopus 로고    scopus 로고
    • The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction
    • Hoyer-Hansen G, Behrendt N, Ploug M, Dano K, Preissner KT. The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction. FEBS Lett 1997; 420: 79-85.
    • (1997) FEBS Lett , vol.420 , pp. 79-85
    • Hoyer-hansen, G.1    Behrendt, N.2    Ploug, M.3    Dano, K.4    Preissner, K.T.5
  • 48
    • 0028569183 scopus 로고
    • Identification of the urokinase receptor as an adhesion receptor for vitronectin
    • Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 1994; 269: 32380-8.
    • (1994) J Biol Chem , vol.269 , pp. 32380-32388
    • Wei, Y.1    Waltz, D.A.2    Rao, N.3    Drummond, R.J.4    Rosenberg, S.5    Chapman, H.A.6
  • 49
    • 0029816265 scopus 로고    scopus 로고
    • Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
    • Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol 1996; 134: 1563-71.
    • (1996) J Cell Biol , vol.134 , pp. 1563-1571
    • Deng, G.1    Curriden, S.A.2    Wang, S.3    Rosenberg, S.4    Loskutoff, D.J.5
  • 50
    • 0029873910 scopus 로고    scopus 로고
    • The urokinase receptor is a major vitronectin-binding protein on endothelial cells
    • Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT. The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res 1996; 224: 344-53.
    • (1996) Exp Cell Res , vol.224 , pp. 344-353
    • Kanse, S.M.1    Kost, C.2    Wilhelm, O.G.3    Andreasen, P.A.4    Preissner, K.T.5
  • 51
    • 0037008781 scopus 로고    scopus 로고
    • Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization
    • Sidenius N, Andolfo A, Fesche R, Blasi F. Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization. J Biol Chem 2002; 277: 27982-90.
    • (2002) J Biol Chem , vol.277 , pp. 27982-27990
    • Sidenius, N.1    Andolfo, A.2    Fesche, R.3    Blasi, F.4
  • 52
    • 0028567891 scopus 로고
    • Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue
    • Plesner T, Ralfkiaer E, Wittrup M, et al. Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. Am J Clin Pathol 1994; 102: 835-41.
    • (1994) Am J Clin Pathol , vol.102 , pp. 835-841
    • Plesner, T.1    Ralfkiaer, E.2    Wittrup, M.3
  • 53
    • 0034650868 scopus 로고    scopus 로고
    • uPA/uPAR system is active in immature dendritic cells derived from CD14+CD34+ precursors and is down-regulated upon maturation
    • Ferrero E, Vettoretto K, Bondanza A, et al. uPA/uPAR system is active in immature dendritic cells derived from CD14+CD34+ precursors and is down-regulated upon maturation. J Immunol 2000; 164: 712-8.
    • (2000) J Immunol , vol.164 , pp. 712-718
    • Ferrero, E.1    Vettoretto, K.2    Bondanza, A.3
  • 54
    • 0026537705 scopus 로고
    • Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells
    • Nykjaer A, Petersen CM, Moller B, Andreasen PA, Gliemann J. Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells. FEBS Lett 1992; 300: 13-7.
    • (1992) FEBS Lett , vol.300 , pp. 13-17
    • Nykjaer, A.1    Petersen, C.M.2    Moller, B.3    Andreasen, P.A.4    Gliemann, J.5
  • 56
    • 0029757446 scopus 로고    scopus 로고
    • Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes
    • Bianchi E, Ferrero E, Fazioli F, et al. Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. J Clin Invest 1996; 98: 1133-41.
    • (1996) J Clin Invest , vol.98 , pp. 1133-1141
    • Bianchi, E.1    Ferrero, E.2    Fazioli, F.3
  • 58
    • 0025838338 scopus 로고
    • Urokinase binding and receptor identification in cultured endothelial cells
    • Haddock RC, Spell ML, Baker CD III, et al. Urokinase binding and receptor identification in cultured endothelial cells. J Biol Chem 1991; 266: 21466-73.
    • (1991) J Biol Chem , vol.266 , pp. 21466-21473
    • Haddock, R.C.1    Spell, M.L.2    Baker III, C.D.3
  • 59
    • 0032055937 scopus 로고    scopus 로고
    • Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes
    • Chavakis T, Kanse SM, Yutzy B, Lijnen HR, Preissner KT. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes. Blood 1998; 91: 2305-12.
    • (1998) Blood , vol.91 , pp. 2305-2312
    • Chavakis, T.1    Kanse, S.M.2    Yutzy, B.3    Lijnen, H.R.4    Preissner, K.T.5
  • 61
    • 0034672473 scopus 로고    scopus 로고
    • Enhanced release of soluble urokinase receptor by endothelial cells in contact with peripheral blood cells
    • Mustjoki S, Sidenius N, Vaheri A. Enhanced release of soluble urokinase receptor by endothelial cells in contact with peripheral blood cells. FEBS Lett 2000; 486: 237-42.
    • (2000) FEBS Lett , vol.486 , pp. 237-242
    • Mustjoki, S.1    Sidenius, N.2    Vaheri, A.3
  • 62
    • 0033614835 scopus 로고    scopus 로고
    • Urokinase receptor (uPAR, CD87) is a platelet receptor important for kinetics and TNF-induced endothelial adhesion in mice
    • Piguet PF, Vesin C, Donati Y, Tacchini-Cottier F, Belin D, Barazzone C. Urokinase receptor (uPAR, CD87) is a platelet receptor important for kinetics and TNF-induced endothelial adhesion in mice. Circulation 1999; 99: 3315-21.
    • (1999) Circulation , vol.99 , pp. 3315-3321
    • Piguet, P.F.1    Vesin, C.2    Donati, Y.3    Tacchini-cottier, F.4    Belin, D.5    Barazzone, C.6
  • 63
    • 0030782196 scopus 로고    scopus 로고
    • Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR
    • Plesner T, Behrendt N, Ploug M. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells 1997; 15: 398-408.
    • (1997) Stem Cells , vol.15 , pp. 398-408
    • Plesner, T.1    Behrendt, N.2    Ploug, M.3
  • 64
    • 0026644421 scopus 로고
    • Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain
    • Hoyer-Hansen G, Ronne E, Solberg H, et al. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem 1992; 267: 18224-9.
    • (1992) J Biol Chem , vol.267 , pp. 18224-18229
    • Hoyer-hansen, G.1    Ronne, E.2    Solberg, H.3
  • 66
    • 0033059340 scopus 로고    scopus 로고
    • Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression
    • Wilhelm OG, Wilhelm S, Escott GM, et al. Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression. J Cell Physiol 1999; 180: 225-35.
    • (1999) J Cell Physiol , vol.180 , pp. 225-235
    • Wilhelm, O.G.1    Wilhelm, S.2    Escott, G.M.3
  • 67
    • 58249126233 scopus 로고    scopus 로고
    • Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87)
    • Pliyev BK. Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87). Mol Cell Biochem 2009; 321: 111-22.
    • (2009) Mol Cell Biochem , vol.321 , pp. 111-122
    • Pliyev, B.K.1
  • 68
    • 0027314980 scopus 로고
    • An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator
    • Pyke C, Eriksen J, Solberg H, et al. An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator. FEBS Lett 1993; 326: 69-74.
    • (1993) FEBS Lett , vol.326 , pp. 69-74
    • Pyke, C.1    Eriksen, J.2    Solberg, H.3
  • 69
    • 0032146117 scopus 로고    scopus 로고
    • Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer
    • Wahlberg K, Hoyer-Hansen G, Casslen B. Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer. Cancer Res 1998; 58: 3294-8.
    • (1998) Cancer Res , vol.58 , pp. 3294-3298
    • Wahlberg, K.1    Hoyer-hansen, G.2    Casslen, B.3
  • 70
    • 0034625509 scopus 로고    scopus 로고
    • Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo
    • Sidenius N, Sier CF, Blasi F. Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo. FEBS Lett 2000; 475: 52-6.
    • (2000) FEBS Lett , vol.475 , pp. 52-56
    • Sidenius, N.1    Sier, C.F.2    Blasi, F.3
  • 71
    • 0034671311 scopus 로고    scopus 로고
    • Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy
    • Mustjoki S, Sidenius N, Sier CF, et al. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy. Cancer Res 2000; 60: 7126-32.
    • (2000) Cancer Res , vol.60 , pp. 7126-7132
    • Mustjoki, S.1    Sidenius, N.2    Sier, C.F.3
  • 72
    • 7044235685 scopus 로고    scopus 로고
    • Specific Immunoassays for Detection of Intact and Cleaved Forms of the Urokinase Receptor
    • Piironen T, Laursen B, Paas J, et al. Specific Immunoassays for Detection of Intact and Cleaved Forms of the Urokinase Receptor. Clin Chem 2004; 50: 2059-68.
    • (2004) Clin Chem , vol.50 , pp. 2059-2068
    • Piironen, T.1    Laursen, B.2    Paas, J.3
  • 73
    • 0030926412 scopus 로고    scopus 로고
    • Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
    • Nykjaer A, Conese M, Christensen EI, et al. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J 1997; 16: 2610-20.
    • (1997) EMBO J , vol.16 , pp. 2610-2620
    • Nykjaer, A.1    Conese, M.2    Christensen, E.I.3
  • 74
    • 0029764639 scopus 로고    scopus 로고
    • Regulation of integrin function by the urokinase receptor
    • Wei Y, Lukashev M, Simon DI, et al. Regulation of integrin function by the urokinase receptor. Science 1996; 273: 1551-5.
    • (1996) Science , vol.273 , pp. 1551-1555
    • Wei, Y.1    Lukashev, M.2    Simon, D.I.3
  • 75
    • 0346736507 scopus 로고    scopus 로고
    • The cleavage of the urokinase receptor regulates its multiple functions
    • Montuori N, Carriero MV, Salzano S, Rossi G, Ragno P. The cleavage of the urokinase receptor regulates its multiple functions. J Biol Chem 2002; 277: 46932-9.
    • (2002) J Biol Chem , vol.277 , pp. 46932-46939
    • Montuori, N.1    Carriero, M.V.2    Salzano, S.3    Rossi, G.4    Ragno, P.5
  • 76
    • 0032555894 scopus 로고    scopus 로고
    • Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo
    • May AE, Kanse SM, Lund LR, Gisler RH, Imhof BA, Preissner KT. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. J Exp Med 1998; 188: 1029-37.
    • (1998) J Exp Med , vol.188 , pp. 1029-1037
    • May, A.E.1    Kanse, S.M.2    Lund, L.R.3    Gisler, R.H.4    Imhof, B.A.5    Preissner, K.T.6
  • 77
    • 0033824172 scopus 로고    scopus 로고
    • Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth
    • Ossowski L, Aguirre-Ghiso JA. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 2000; 12: 613-20.
    • (2000) Curr Opin Cell Biol , vol.12 , pp. 613-620
    • Ossowski, L.1    Aguirre-ghiso, J.A.2
  • 78
    • 0030842795 scopus 로고    scopus 로고
    • Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
    • Chapman HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997; 9: 714-24.
    • (1997) Curr Opin Cell Biol , vol.9 , pp. 714-724
    • Chapman, H.A.1
  • 79
    • 0032695915 scopus 로고    scopus 로고
    • Role of urokinase receptor and caveolin in regulation of integrin signaling
    • Chapman HA, Wei Y, Simon DI, Waltz DA. Role of urokinase receptor and caveolin in regulation of integrin signaling. Thromb Haemost 1999; 82: 291-7.
    • (1999) Thromb Haemost , vol.82 , pp. 291-297
    • Chapman, H.A.1    Wei, Y.2    Simon, D.I.3    Waltz, D.A.4
  • 80
    • 0031746579 scopus 로고    scopus 로고
    • Role of vitronectin and its receptors in haemostasis and vascular remodeling
    • Preissner KT, Seiffert D. Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb Res 1998; 89: 1-21.
    • (1998) Thromb Res , vol.89 , pp. 1-21
    • Preissner, K.T.1    Seiffert, D.2
  • 81
    • 0033818463 scopus 로고    scopus 로고
    • Urokinase receptor: a molecular organizer in cellular communication
    • Preissner KT, Kanse SM, May AE. Urokinase receptor: a molecular organizer in cellular communication. Curr Opin Cell Biol 2000; 12: 621-8.
    • (2000) Curr Opin Cell Biol , vol.12 , pp. 621-628
    • Preissner, K.T.1    Kanse, S.M.2    May, A.E.3
  • 82
    • 0034254823 scopus 로고    scopus 로고
    • Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection
    • Gyetko MR, Sud S, Kendall T, Fuller JA, Newstead MW, Standiford TJ. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J Immunol 2000; 165: 1513-9.
    • (2000) J Immunol , vol.165 , pp. 1513-1519
    • Gyetko, M.R.1    Sud, S.2    Kendall, T.3    Fuller, J.A.4    Newstead, M.W.5    Standiford, T.J.6
  • 83
    • 0035889884 scopus 로고    scopus 로고
    • Cutting Edge: Antigen-Driven Lymphocyte Recruitment to the Lung Is Diminished in the Absence of Urokinase-Type Plasminogen Activator (uPA) Receptor, but Is Independent of uPA
    • Gyetko MR, Sud S, Sonstein J, Polak T, Sud A, Curtis JL. Cutting Edge: Antigen-Driven Lymphocyte Recruitment to the Lung Is Diminished in the Absence of Urokinase-Type Plasminogen Activator (uPA) Receptor, but Is Independent of uPA. J Immunol 2001; 167: 5539-42.
    • (2001) J Immunol , vol.167 , pp. 5539-5542
    • Gyetko, M.R.1    Sud, S.2    Sonstein, J.3    Polak, T.4    Sud, A.5    Curtis, J.L.6
  • 84
    • 0036533484 scopus 로고    scopus 로고
    • Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia
    • Rijneveld AW, Levi M, Florquin S, Speelman P, Carmeliet P, van Der PT. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol 2002; 168: 3507-11.
    • (2002) J Immunol , vol.168 , pp. 3507-3511
    • Rijneveld, A.W.1    Levi, M.2    Florquin, S.3    Speelman, P.4    Carmeliet, P.5    Van Der, P.T.6
  • 85
    • 4344647595 scopus 로고    scopus 로고
    • Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro
    • Gyetko MR, Aizenberg D, Mayo-Bond L. Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro. J Leukoc Biol 2004; 76: 648-56.
    • (2004) J Leukoc Biol , vol.76 , pp. 648-656
    • Gyetko, M.R.1    Aizenberg, D.2    Mayo-bond, L.3
  • 86
    • 0035830838 scopus 로고    scopus 로고
    • Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction
    • Tarui T, Mazar AP, Cines DB, Takada Y. Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction. J Biol Chem 2001; 276: 3983-90.
    • (2001) J Biol Chem , vol.276 , pp. 3983-3990
    • Tarui, T.1    Mazar, A.P.2    Cines, D.B.3    Takada, Y.4
  • 87
    • 0031463337 scopus 로고    scopus 로고
    • A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity
    • Fazioli F, Resnati M, Sidenius N, Higashimoto Y, Appella E, Blasi F. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J 1997; 16: 7279-86.
    • (1997) EMBO J , vol.16 , pp. 7279-7286
    • Fazioli, F.1    Resnati, M.2    Sidenius, N.3    Higashimoto, Y.4    Appella, E.5    Blasi, F.6
  • 88
    • 0037022391 scopus 로고    scopus 로고
    • The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R
    • Resnati M, Pallavicini I, Wang JM, et al. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci USA 2002; 99: 1359-64.
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 1359-1364
    • Resnati, M.1    Pallavicini, I.2    Wang, J.M.3
  • 89
    • 0034695451 scopus 로고    scopus 로고
    • A urokinase receptor-associated protein with specific collagen binding properties
    • Behrendt N, Jensen ON, Engelholm LH, Mortz E, Mann M, Dano K. A urokinase receptor-associated protein with specific collagen binding properties. J Biol Chem 2000; 275: 1993-2002.
    • (2000) J Biol Chem , vol.275 , pp. 1993-2002
    • Behrendt, N.1    Jensen, O.N.2    Engelholm, L.H.3    Mortz, E.4    Mann, M.5    Dano, K.6
  • 90
    • 0029923744 scopus 로고    scopus 로고
    • Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect
    • Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J 1996; 15: 1572-82.
    • (1996) EMBO J , vol.15 , pp. 1572-1582
    • Resnati, M.1    Guttinger, M.2    Valcamonica, S.3    Sidenius, N.4    Blasi, F.5    Fazioli, F.6
  • 91
    • 0033659692 scopus 로고    scopus 로고
    • Novel pathophysiological role of classical chemotactic peptide receptors and their communications with chemokine receptors
    • 185-94
    • Le Y, Li B, Gong W, et al. Novel pathophysiological role of classical chemotactic peptide receptors and their communications with chemokine receptors. Immunol Rev 2000; 177: 185-94.: 185-94.
    • (2000) Immunol Rev , vol.177 , pp. 185-194
    • Le, Y.1    Li, B.2    Gong, W.3
  • 92
    • 4344614173 scopus 로고    scopus 로고
    • The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion
    • Furlan F, Orlando S, Laudanna C, et al. The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion. J Cell Sci 2004; 117: 2909-16.
    • (2004) J Cell Sci , vol.117 , pp. 2909-2916
    • Furlan, F.1    Orlando, S.2    Laudanna, C.3
  • 93
    • 33745521267 scopus 로고    scopus 로고
    • Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy
    • Ostrowski SR, Katzenstein TL, Pedersen M, et al. Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy. Scand J Immunol 2006; 63: 478-86.
    • (2006) Scand J Immunol , vol.63 , pp. 478-486
    • Ostrowski, S.R.1    Katzenstein, T.L.2    Pedersen, M.3
  • 95
    • 0032855119 scopus 로고    scopus 로고
    • Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies
    • Holst-Hansen C, Hamers MJ, Johannessen BE, Brunner N, Stephens RW. Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies. Br J Cancer 1999; 81: 203-11.
    • (1999) Br J Cancer , vol.81 , pp. 203-211
    • Holst-hansen, C.1    Hamers, M.J.2    Johannessen, B.E.3    Brunner, N.4    Stephens, R.W.5
  • 96
    • 20144382507 scopus 로고    scopus 로고
    • Involvement of the Urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization
    • Selleri C, Montuori N, Ricci P, et al. Involvement of the Urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood 2005; 105: 2198-205.
    • (2005) Blood , vol.105 , pp. 2198-2205
    • Selleri, C.1    Montuori, N.2    Ricci, P.3
  • 97
    • 33845313656 scopus 로고    scopus 로고
    • In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer
    • Selleri C, Montuori N, Ricci P, et al. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. Cancer Res 2006; 66: 10885-90.
    • (2006) Cancer Res , vol.66 , pp. 10885-10890
    • Selleri, C.1    Montuori, N.2    Ricci, P.3
  • 98
    • 0036519468 scopus 로고    scopus 로고
    • Meassurements of soluble urokinase plasminogen activator receptor in serum
    • Riisbro R, Piironen T, Brünner N, et al. Meassurements of soluble urokinase plasminogen activator receptor in serum. J Clin Ligand Assay 2002; 25: 53-6.
    • (2002) J Clin Ligand Assay , vol.25 , pp. 53-56
    • Riisbro, R.1    Piironen, T.2    Brünner, N.3
  • 99
    • 0032530889 scopus 로고    scopus 로고
    • Lysis of plasma clots by urokinase-soluble urokinase receptor complexes
    • Higazi AA, Bdeir K, Hiss E, et al. Lysis of plasma clots by urokinase-soluble urokinase receptor complexes. Blood 1998; 92: 2075-83.
    • (1998) Blood , vol.92 , pp. 2075-2083
    • Higazi, A.A.1    Bdeir, K.2    Hiss, E.3
  • 100
    • 0344442849 scopus 로고    scopus 로고
    • Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions
    • Cunningham O, Andolfo A, Santovito ML, Iuzzolino L, Blasi F, Sidenius N. Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J 2003; 22: 5994-6003.
    • (2003) EMBO J , vol.22 , pp. 5994-6003
    • Cunningham, O.1    Andolfo, A.2    Santovito, M.L.3    Iuzzolino, L.4    Blasi, F.5    Sidenius, N.6
  • 101
    • 0034687545 scopus 로고    scopus 로고
    • Soluble urokinase receptor promotes cell adhesion and requires tyrosine-92 for activation of p56/59(hck)
    • Trigwell S, Wood L, Jones P. Soluble urokinase receptor promotes cell adhesion and requires tyrosine-92 for activation of p56/59(hck). Biochem Biophys Res Commun 2000; 278: 440-6.
    • (2000) Biochem Biophys Res Commun , vol.278 , pp. 440-446
    • Trigwell, S.1    Wood, L.2    Jones, P.3
  • 102
    • 0031928022 scopus 로고    scopus 로고
    • A soluble form of the urokinase plasminogen activator receptor (suPAR) can bind to hematopoietic cells
    • Mizukami IF, Todd RF. A soluble form of the urokinase plasminogen activator receptor (suPAR) can bind to hematopoietic cells. J Leukoc Biol 1998; 64: 203-13.
    • (1998) J Leukoc Biol , vol.64 , pp. 203-213
    • Mizukami, I.F.1    Todd, R.F.2
  • 104
    • 0039770451 scopus 로고    scopus 로고
    • Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)
    • Kruger A, Soeltl R, Lutz V, et al. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87). Cancer Gene Ther 2000; 7: 292-9.
    • (2000) Cancer Gene Ther , vol.7 , pp. 292-299
    • Kruger, A.1    Soeltl, R.2    Lutz, V.3
  • 105
    • 0034930530 scopus 로고    scopus 로고
    • High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice
    • Lutz V, Reuning U, Kruger A, et al. High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice. Biol Chem 2001; 382: 789-98.
    • (2001) Biol Chem , vol.382 , pp. 789-798
    • Lutz, V.1    Reuning, U.2    Kruger, A.3
  • 106
    • 0002460807 scopus 로고    scopus 로고
    • Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling
    • Aguirre Ghiso JA, Kovalski K, Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 1999; 147: 89-104.
    • (1999) J Cell Biol , vol.147 , pp. 89-104
    • Aguirre Ghiso, J.A.1    Kovalski, K.2    Ossowski, L.3
  • 107
    • 0031902711 scopus 로고    scopus 로고
    • Urokinase plasminogen activator receptor (uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection
    • Speth C, Pichler I, Stockl G, Mair M, Dierich MP. Urokinase plasminogen activator receptor (uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection. Immunobiology 1998; 199: 152-62.
    • (1998) Immunobiology , vol.199 , pp. 152-162
    • Speth, C.1    Pichler, I.2    Stockl, G.3    Mair, M.4    Dierich, M.P.5
  • 108
    • 0029853890 scopus 로고    scopus 로고
    • Acquisition of host cell-surface-derived molecules by HIV-1
    • Frank I, Stoiber H, Godar S, et al. Acquisition of host cell-surface-derived molecules by HIV-1. AIDS 1996; 10: 1611-20.
    • (1996) AIDS , vol.10 , pp. 1611-1620
    • Frank, I.1    Stoiber, H.2    Godar, S.3
  • 109
    • 11144358195 scopus 로고    scopus 로고
    • The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations
    • Cinque P, Nebuloni M, Santovito ML, et al. The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations. Ann Neurol 2004; 55: 687-94.
    • (2004) Ann Neurol , vol.55 , pp. 687-694
    • Cinque, P.1    Nebuloni, M.2    Santovito, M.L.3
  • 110
    • 9644259183 scopus 로고    scopus 로고
    • Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease
    • Sidenius N, Nebuloni M, Sala S, et al. Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease. J Neuroimmunol 2004; 157: 133-9.
    • (2004) J Neuroimmunol , vol.157 , pp. 133-139
    • Sidenius, N.1    Nebuloni, M.2    Sala, S.3
  • 111
    • 0036225110 scopus 로고    scopus 로고
    • Decreased urokinase receptor expression on granulocytes in HIV-infected patients
    • Storgaard M, Obel N, Black FT, Moller BK. Decreased urokinase receptor expression on granulocytes in HIV-infected patients. Scand J Immunol 2002; 55: 409-13.
    • (2002) Scand J Immunol , vol.55 , pp. 409-413
    • Storgaard, M.1    Obel, N.2    Black, F.T.3    Moller, B.K.4
  • 112
    • 0031928021 scopus 로고    scopus 로고
    • Altered levels of urokinase on monocytes and in serum of children with AIDS; effects on lymphocyte activation and surface marker expression
    • Murali R, Wolfe JH, Erber R, et al. Altered levels of urokinase on monocytes and in serum of children with AIDS; effects on lymphocyte activation and surface marker expression. J Leukoc Biol 1998; 64: 198-202.
    • (1998) J Leukoc Biol , vol.64 , pp. 198-202
    • Murali, R.1    Wolfe, J.H.2    Erber, R.3
  • 113
    • 0030011633 scopus 로고    scopus 로고
    • A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages
    • Handley MA, Steigbigel RT, Morrison SA. A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages. J Virol 1996; 70: 4451-6.
    • (1996) J Virol , vol.70 , pp. 4451-4456
    • Handley, M.A.1    Steigbigel, R.T.2    Morrison, S.A.3
  • 114
    • 0023508507 scopus 로고
    • Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line
    • Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987; 238: 800-2.
    • (1987) Science , vol.238 , pp. 800-802
    • Folks, T.M.1    Justement, J.2    Kinter, A.3    Dinarello, C.A.4    Fauci, A.S.5
  • 115
    • 0034694019 scopus 로고    scopus 로고
    • Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties
    • Detheux M, Standker L, Vakili J, et al. Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties. J Exp Med 2000; 192: 1501-8.
    • (2000) J Exp Med , vol.192 , pp. 1501-1508
    • Detheux, M.1    Standker, L.2    Vakili, J.3
  • 116
  • 117
    • 0031806811 scopus 로고    scopus 로고
    • Complexes between urokinase-type plasminogen activator and its receptor in blood as determined by enzyme-linked immunosorbent assay
    • De Witte H, Sweep F, Brunner N, et al. Complexes between urokinase-type plasminogen activator and its receptor in blood as determined by enzyme-linked immunosorbent assay. Int J Cancer 1998; 77: 236-42.
    • (1998) Int J Cancer , vol.77 , pp. 236-242
    • De Witte, H.1    Sweep, F.2    Brunner, N.3
  • 118
    • 18344388812 scopus 로고    scopus 로고
    • Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients
    • Ostrowski SR, Piironen T, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H. Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients. Scand J Immunol 2005; 61: 347-56.
    • (2005) Scand J Immunol , vol.61 , pp. 347-356
    • Ostrowski, S.R.1    Piironen, T.2    Høyer-hansen, G.3    Gerstoft, J.4    Pedersen, B.K.5    Ullum, H.6
  • 119
    • 0022195209 scopus 로고
    • Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e
    • Todd RF, III, Alvarez PA, Brott DA, Liu DY. Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e. J Immunol 1985; 135: 3869-77.
    • (1985) J Immunol , vol.135 , pp. 3869-3877
    • Todd III, R.F.1    Alvarez, P.A.2    Brott, D.A.3    Liu, D.Y.4
  • 120
    • 0035160526 scopus 로고    scopus 로고
    • Borrelia burgdorferi and other bacterial products induce expression and release of the urokinase receptor (CD87)
    • Coleman JL, Gebbia JA, Benach JL. Borrelia burgdorferi and other bacterial products induce expression and release of the urokinase receptor (CD87). J Immunol 2001; 166: 473-80.
    • (2001) J Immunol , vol.166 , pp. 473-480
    • Coleman, J.L.1    Gebbia, J.A.2    Benach, J.L.3
  • 121
    • 0034923770 scopus 로고    scopus 로고
    • Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia
    • Juffermans NP, Dekkers PE, Verbon A, Speelman P, van Deventer SJ, van Der PT. Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia. Infect Immun 2001; 69: 5182-5.
    • (2001) Infect Immun , vol.69 , pp. 5182-5185
    • Juffermans, N.P.1    Dekkers, P.E.2    Verbon, A.3    Speelman, P.4    Van Deventer, S.J.5    van Der, P.T.6
  • 122
    • 0141669098 scopus 로고    scopus 로고
    • The urokinase receptor can be induced by Borrelia burgdorferi through receptors of the innate immune system
    • Coleman JL, Benach JL. The urokinase receptor can be induced by Borrelia burgdorferi through receptors of the innate immune system. Infect Immun 2003; 71: 5556-64.
    • (2003) Infect Immun , vol.71 , pp. 5556-5564
    • Coleman, J.L.1    Benach, J.L.2
  • 123
    • 37549009178 scopus 로고    scopus 로고
    • Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy
    • Andersen O, Eugen-Olsen J, Kofoed K, Iversen J, Haugaard SB. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy. J Med Virol 2008; 80: 209-16.
    • (2008) J Med Virol , vol.80 , pp. 209-216
    • Andersen, O.1    Eugen-olsen, J.2    Kofoed, K.3    Iversen, J.4    Haugaard, S.B.5
  • 124
    • 0030057250 scopus 로고    scopus 로고
    • Modulation of the receptor for urokinase-type plasminogen activator in macrophage-like U937 cells by inflammatory mediators
    • Yoshida E, Tsuchiya K, Sugiki M, Sumi H, Mihara H, Maruyama M. Modulation of the receptor for urokinase-type plasminogen activator in macrophage-like U937 cells by inflammatory mediators. Inflammation 1996; 20: 319-26.
    • (1996) Inflammation , vol.20 , pp. 319-326
    • Yoshida, E.1    Tsuchiya, K.2    Sugiki, M.3    Sumi, H.4    Mihara, H.5    Maruyama, M.6
  • 125
    • 0024207036 scopus 로고
    • IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes
    • Kirchheimer JC, Nong YH, Remold HG. IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes. J Immunol 1988; 141: 4229-34.
    • (1988) J Immunol , vol.141 , pp. 4229-4234
    • Kirchheimer, J.C.1    Nong, Y.H.2    Remold, H.G.3
  • 126
    • 0028049507 scopus 로고
    • Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes
    • Sitrin RG, Todd RF, III, Mizukami IF, Gross TJ, Shollenberger SB, Gyetko MR. Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood 1994; 84: 1268-75.
    • (1994) Blood , vol.84 , pp. 1268-1275
    • Sitrin, R.G.1    Todd III, R.F.2    Mizukami, I.F.3    Gross, T.J.4    Shollenberger, S.B.5    Gyetko, M.R.6
  • 127
    • 0028031885 scopus 로고
    • The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils
    • Plesner T, Ploug M, Ellis V, et al. The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood 1994; 83: 808-15.
    • (1994) Blood , vol.83 , pp. 808-815
    • Plesner, T.1    Ploug, M.2    Ellis, V.3
  • 128
    • 0036285804 scopus 로고    scopus 로고
    • IL-2-mediated upregulation of uPA and uPAR in natural killer cells
    • Al Atrash G, Shetty S, Idell S, et al. IL-2-mediated upregulation of uPA and uPAR in natural killer cells. Biochem Biophys Res Commun 2002; 292: 184-9.
    • (2002) Biochem Biophys Res Commun , vol.292 , pp. 184-189
    • Al Atrash, G.1    Shetty, S.2    Idell, S.3
  • 129
    • 0031961954 scopus 로고    scopus 로고
    • Regulation of the uPAR/uPA system expressed on monocytes by the deactivating cytokines, IL-4, IL-10 and IL-13: consequences on cell adhesion to vitronectin and fibrinogen
    • Paysant J, Vasse M, Soria J, et al. Regulation of the uPAR/uPA system expressed on monocytes by the deactivating cytokines, IL-4, IL-10 and IL-13: consequences on cell adhesion to vitronectin and fibrinogen. Br J Haematol 1998; 100: 45-51.
    • (1998) Br J Haematol , vol.100 , pp. 45-51
    • Paysant, J.1    Vasse, M.2    Soria, J.3
  • 130
    • 0028014557 scopus 로고
    • Cell-surface plasminogen activation causes a retraction of in vitro cultured human umbilical vein endothelial cell monolayer
    • Conforti G, Dominguez-Jimenez C, Ronne E, Hoyer-Hansen G, Dejana E. Cell-surface plasminogen activation causes a retraction of in vitro cultured human umbilical vein endothelial cell monolayer. Blood 1994; 83: 994-1005.
    • (1994) Blood , vol.83 , pp. 994-1005
    • Conforti, G.1    Dominguez-jimenez, C.2    Ronne, E.3    Hoyer-hansen, G.4    Dejana, E.5
  • 131
    • 0030007064 scopus 로고    scopus 로고
    • Impaired wound healing in mice with a disrupted plasminogen gene
    • Romer J, Bugge TH, Pyke C, et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996; 2: 287-92.
    • (1996) Nat Med , vol.2 , pp. 287-292
    • Romer, J.1    Bugge, T.H.2    Pyke, C.3
  • 132
    • 0033199235 scopus 로고    scopus 로고
    • Functional overlap between two classes of matrix-degrading proteases in wound healing
    • Lund LR, Romer J, Bugge TH, et al. Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J 1999; 18: 4645-56.
    • (1999) EMBO J , vol.18 , pp. 4645-4656
    • Lund, L.R.1    Romer, J.2    Bugge, T.H.3
  • 133
    • 0029082279 scopus 로고
    • Endotoxin stimulates expression of the murine urokinase receptor gene in vivo
    • Almus-Jacobs F, Varki N, Sawdey MS, Loskutoff DJ. Endotoxin stimulates expression of the murine urokinase receptor gene in vivo. Am J Pathol 1995; 147: 688-98.
    • (1995) Am J Pathol , vol.147 , pp. 688-698
    • Almus-jacobs, F.1    Varki, N.2    Sawdey, M.S.3    Loskutoff, D.J.4
  • 134
    • 0035147370 scopus 로고    scopus 로고
    • The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling
    • Solberg H, Ploug M, Hoyer-Hansen G, Nielsen BS, Lund LR. The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling. J Histochem Cytochem 2001; 49: 237-46.
    • (2001) J Histochem Cytochem , vol.49 , pp. 237-246
    • Solberg, H.1    Ploug, M.2    Hoyer-hansen, G.3    Nielsen, B.S.4    Lund, L.R.5
  • 135
    • 0028327420 scopus 로고
    • The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds
    • Romer J, Lund LR, Eriksen J, Pyke C, Kristensen P, Dano K. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. J Invest Dermatol 1994; 102: 519-22.
    • (1994) J Invest Dermatol , vol.102 , pp. 519-522
    • Romer, J.1    Lund, L.R.2    Eriksen, J.3    Pyke, C.4    Kristensen, P.5    Dano, K.6
  • 136
    • 0004266915 scopus 로고    scopus 로고
    • Pathology
    • Third ed. Philadelphia, US: Lippincott-Raven Publishers
    • Rubin E, Farcet JP. Pathology. Third ed. Philadelphia, US: Lippincott-Raven Publishers, 1999.
    • (1999)
    • Rubin, E.1    Farcet, J.P.2
  • 137
    • 0142092389 scopus 로고    scopus 로고
    • Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy
    • Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003; 77: 11708-17.
    • (2003) J Virol , vol.77 , pp. 11708-11717
    • Guadalupe, M.1    Reay, E.2    Sankaran, S.3
  • 138
    • 4644289983 scopus 로고    scopus 로고
    • Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract
    • Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200: 761-70.
    • (2004) J Exp Med , vol.200 , pp. 761-770
    • Mehandru, S.1    Poles, M.A.2    Tenner-racz, K.3
  • 139
    • 4644342929 scopus 로고    scopus 로고
    • CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
    • Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200: 749-59.
    • (2004) J Exp Med , vol.200 , pp. 749-759
    • Brenchley, J.M.1    Schacker, T.W.2    Ruff, L.E.3
  • 140
    • 37349078686 scopus 로고    scopus 로고
    • Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration
    • Sankaran S, George MD, Reay E, et al. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 2008; 82: 538-45.
    • (2008) J Virol , vol.82 , pp. 538-545
    • Sankaran, S.1    George, M.D.2    Reay, E.3
  • 141
    • 18244361800 scopus 로고    scopus 로고
    • HIV pathogenesis: the first cut is the deepest
    • Picker LJ, Watkins DI. HIV pathogenesis: the first cut is the deepest. Nat Immunol 2005; 6: 430-2.
    • (2005) Nat Immunol , vol.6 , pp. 430-432
    • Picker, L.J.1    Watkins, D.I.2
  • 142
    • 33644822414 scopus 로고    scopus 로고
    • Pathogenesis of HIV infection: what the virus spares is as important as what it destroys
    • Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 2006; 12: 289-95.
    • (2006) Nat Med , vol.12 , pp. 289-295
    • Grossman, Z.1    Meier-schellersheim, M.2    Paul, W.E.3    Picker, L.J.4
  • 143
    • 0025069873 scopus 로고
    • The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1
    • Fahey JL, Taylor JM, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990; 322: 166-72.
    • (1990) N Engl J Med , vol.322 , pp. 166-172
    • Fahey, J.L.1    Taylor, J.M.2    Detels, R.3
  • 144
    • 0032504919 scopus 로고    scopus 로고
    • Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements
    • Fahey JL, Taylor JM, Manna B, et al. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS 1998; 12: 1581-90.
    • (1998) AIDS , vol.12 , pp. 1581-1590
    • Fahey, J.L.1    Taylor, J.M.2    Manna, B.3
  • 145
    • 0030668834 scopus 로고    scopus 로고
    • Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression
    • Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, Giorgi JV. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 83-92.
    • (1997) J Acquir Immune Defic Syndr Hum Retrovirol , vol.16 , pp. 83-92
    • Liu, Z.1    Cumberland, W.G.2    Hultin, L.E.3    Prince, H.E.4    Detels, R.5    Giorgi, J.V.6
  • 147
    • 0032955651 scopus 로고    scopus 로고
    • Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage
    • Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179: 859-70.
    • (1999) J Infect Dis , vol.179 , pp. 859-870
    • Giorgi, J.V.1    Hultin, L.E.2    McKeating, J.A.3
  • 148
    • 12644311247 scopus 로고    scopus 로고
    • CD8+, CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients
    • Mocroft A, Bofill M, Lipman M, et al. CD8+, CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 158-62.
    • (1997) J Acquir Immune Defic Syndr Hum Retrovirol , vol.14 , pp. 158-162
    • Mocroft, A.1    Bofill, M.2    Lipman, M.3
  • 149
    • 0041327667 scopus 로고    scopus 로고
    • Persistent immune activation in HIV-1 infection is associated with progression to AIDS
    • Hazenberg MD, Otto SA, van Benthem BH, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17: 1881-8.
    • (2003) AIDS , vol.17 , pp. 1881-1888
    • Hazenberg, M.D.1    Otto, S.A.2    Van Benthem, B.H.3
  • 150
    • 3843056825 scopus 로고    scopus 로고
    • Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
    • Deeks SG, Kitchen CM, Liu L, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004; 104: 942-7.
    • (2004) Blood , vol.104 , pp. 942-947
    • Deeks, S.G.1    Kitchen, C.M.2    Liu, L.3
  • 151
    • 49849088558 scopus 로고    scopus 로고
    • Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts
    • Pandrea I, Sodora DL, Silvestri G, Apetrei C. Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts. Trends Immunol 2008; 29: 419-28.
    • (2008) Trends Immunol , vol.29 , pp. 419-428
    • Pandrea, I.1    Sodora, D.L.2    Silvestri, G.3    Apetrei, C.4
  • 152
    • 0036103096 scopus 로고    scopus 로고
    • CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?
    • Nat Med
    • Grossman Z, Meier-Schellersheim M, Sousa AE, Victorino RM, Paul WE. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat Med 2002; 8: 319-23.
    • (2002) , vol.8 , pp. 319-323
    • Grossman, Z.1    Meier-schellersheim, M.2    Sousa, A.E.3    Victorino, R.M.4    Paul, W.E.5
  • 153
    • 0034304597 scopus 로고    scopus 로고
    • T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock
    • Hazenberg MD, Hamann D, Schuitemaker H, Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol 2000; 1: 285-9.
    • (2000) Nat Immunol , vol.1 , pp. 285-289
    • Hazenberg, M.D.1    Hamann, D.2    Schuitemaker, H.3    Miedema, F.4
  • 154
    • 58149177783 scopus 로고    scopus 로고
    • Cutting Edge: Experimentally Induced Immune Activation in Natural Hosts of Simian Immunodeficiency Virus Induces significant Increases in Viral Replication and CD4 T Cell Depletion
    • Pandrea I, Gaufin T, Brenchley JM, et al. Cutting Edge: Experimentally Induced Immune Activation in Natural Hosts of Simian Immunodeficiency Virus Induces significant Increases in Viral Replication and CD4 T Cell Depletion. J Immunol 2008; 181: 6687-91.
    • (2008) J Immunol , vol.181 , pp. 6687-6691
    • Pandrea, I.1    Gaufin, T.2    Brenchley, J.M.3
  • 155
    • 0142186676 scopus 로고    scopus 로고
    • Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection
    • Hellerstein MK, Hoh RA, Hanley MB, et al. Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J Clin Invest 2003; 112: 956-66.
    • (2003) J Clin Invest , vol.112 , pp. 956-966
    • Hellerstein, M.K.1    Hoh, R.A.2    Hanley, M.B.3
  • 156
    • 0037340417 scopus 로고    scopus 로고
    • Lineage relationship and protective immunity of memory CD8 T cell subsets
    • Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4: 225-34.
    • (2003) Nat Immunol , vol.4 , pp. 225-234
    • Wherry, E.J.1    Teichgraber, V.2    Becker, T.C.3
  • 157
    • 46149112761 scopus 로고    scopus 로고
    • suPAR associates to glucose metabolic aberration during glucose stimulation in HIV-infected patients on HAART
    • Andersen O, Eugen-Olsen J, Kofoed K, Iversen J, Haugaard SB. suPAR associates to glucose metabolic aberration during glucose stimulation in HIV-infected patients on HAART. J Infect 2008; 57: 55-63.
    • (2008) J Infect , vol.57 , pp. 55-63
    • Andersen, O.1    Eugen-olsen, J.2    Kofoed, K.3    Iversen, J.4    Haugaard, S.B.5
  • 158
    • 0034767911 scopus 로고    scopus 로고
    • Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection
    • Lawn SD, Butera ST, Folks TM. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 2001; 14: 753-77.
    • (2001) Clin Microbiol Rev , vol.14 , pp. 753-777
    • Lawn, S.D.1    Butera, S.T.2    Folks, T.M.3
  • 159
    • 0036801658 scopus 로고    scopus 로고
    • Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis
    • Schacker TW, Nguyen PL, Beilman GJ, et al. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest 2002; 110: 1133-9.
    • (2002) J Clin Invest , vol.110 , pp. 1133-1139
    • Schacker, T.W.1    Nguyen, P.L.2    Beilman, G.J.3
  • 160
    • 48749093073 scopus 로고    scopus 로고
    • Collagen deposition limits immune reconstitution in the gut
    • Estes J, Baker JV, Brenchley JM, et al. Collagen deposition limits immune reconstitution in the gut. J Infect Dis 2008; 198: 456-64.
    • (2008) J Infect Dis , vol.198 , pp. 456-464
    • Estes, J.1    Baker, J.V.2    Brenchley, J.M.3
  • 161
    • 0030868897 scopus 로고    scopus 로고
    • Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
    • Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277: 112-6.
    • (1997) Science , vol.277 , pp. 112-116
    • Autran, B.1    Carcelain, G.2    Li, T.S.3
  • 162
    • 0034319260 scopus 로고    scopus 로고
    • The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation
    • Cohen Stuart JW, Hazebergh MD, Hamann D, et al. The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation. J Acquir Immune Defic Syndr 2000; 25: 203-11.
    • (2000) J Acquir Immune Defic Syndr , vol.25 , pp. 203-211
    • Cohen Stuart, J.W.1    Hazebergh, M.D.2    Hamann, D.3
  • 163
    • 0032928963 scopus 로고    scopus 로고
    • Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure
    • Aukrust P, Muller F, Lien E, et al. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis 1999; 179: 74-82.
    • (1999) J Infect Dis , vol.179 , pp. 74-82
    • Aukrust, P.1    Muller, F.2    Lien, E.3
  • 164
    • 0032955893 scopus 로고    scopus 로고
    • IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy
    • Stylianou E, Aukrust P, Kvale D, Muller F, Froland SS. IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol 1999; 116: 115-20.
    • (1999) Clin Exp Immunol , vol.116 , pp. 115-120
    • Stylianou, E.1    Aukrust, P.2    Kvale, D.3    Muller, F.4    Froland, S.S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.